Evidence map›Paper›PMID 38816637›Full record

SynthesisChinese journal of integrative medicine2024

Chemical Constituents and Pharmacological Properties of Frankincense: Implications for Anticancer Therapy.

Yong-Rong Wu, Wei Xiong, Ying-Jing Dong, Xin Chen, Yuan-Yuan Zhong, Xin-Ling He, Yu-Jia Wang, Qun-Fang Lin, Xue-Fei Tian, Qing Zhou

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Chinese journal of integrative medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yong-Rong WuCollege of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, 410208, China.
Wei XiongDepartment of Andrology, the First Hospital of Hunan University of Chinese Medicine, Changsha, 41007, China.
Ying-Jing DongCollege of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, 410208, China.
Xin ChenCollege of Medicine, Hunan University of Chinese Medicine, Changsha, 410208, China.
Yuan-Yuan ZhongCollege of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, 410208, China.
Xin-Ling HeCollege of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, 410208, China.
Yu-Jia WangCollege of Traditional Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, 410208, China.
Qun-Fang LinDepartment of Andrology, the First Hospital of Hunan University of Chinese Medicine, Changsha, 41007, China.
Xue-Fei TianCollege of Traditional Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, 410208, China.
Qing ZhouDepartment of Andrology, the First Hospital of Hunan University of Chinese Medicine, Changsha, 41007, China. 310094@hnucm.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The discovery of novel antitumor agents derived from natural plants is a principal objective of anticancer drug research. Frankincense, a widely recognized natural antitumor medicine, has undergone a systematic review encompassing its species, chemical constituents, and diverse pharmacological activities and mechanisms. The different species of frankincense include Boswellia serrata, Somali frankincense, Boswellia frereana, and Boswellia arabica. Various frankincense extracts and compounds exhibit antitumor, anti-inflammatory, and hepatoprotective properties and antioxidation, memory enhancement, and immunological regulation capabilities. They also have comprehensive effects on regulating flora. Frankincense and its principal chemical constituents have demonstrated promising chemoprophylactic and therapeutic abilities against tumors. This review provides a systematic summary of the mechanism of action underlying the antitumor effects of frankincense and its major constituents, thus laying the foundations for developing effective tumor-combating targets.

Indexed as

Antineoplastic AgentsFrankincensePlant ExtractsAnimalsHumansNeoplasmsAntineoplastic AgentsFrankincensePlant Extractsanticancer therapychemical constituentsChinese medicinefrankincensespecies

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.